NAS:DNLI (USA) Also Trade In: Germany

Denali Therapeutics Inc $ 24.9 1.5 (6.41%)

Volume:
1,483,490
Avg Vol (1m):
416,947
Market Cap $:
2.39 Bil
Enterprise Value $:
1.98 Bil
P/E (TTM):
0.00
P/B:
5.46
Warning! GuruFocus has detected 3 Severe warning signs with DNLI. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

DNLI Stock Institutional Ownership and Insider Ownership - Denali Therapeutics

87.48
(Mil)
Shares Outstanding
90.9%
87.12 (Mil)
Institutional Ownership
4.66%
4.47 (Mil)
Insider Ownership
50.71%
44.36 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Denali Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Denali Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders